Advertisement

Ads Placeholder
Loading...

Quantum BioPharma Ltd.

QNTM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.98
$-0.43(-9.75%)
U.S. Market opens in 0h 44m

Quantum BioPharma Ltd. (QNTM) Stock Overview

Explore Quantum BioPharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap16.4M
P/E Ratio-0.59
EPS (TTM)$-8.20
ROE-4.19%
Fundamental Analysis

AI Price Forecasts

1 Month$3.72
3 Months$20.12
1 Year Target$0.00

QNTM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Quantum BioPharma Ltd. (QNTM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.59 and a market capitalization of 16.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-9.75%
5-Day Change
7.28%
1-Month Change
6.13%
3-Month Change
-43.22%
6-Month Change
-78.43%
Year-to-Date (YTD) Change
-43.22%
1-Year Change
-49.36%
3-Year Change
-96.02%
5-Year Change
-96.79%
All-Time (Max) Change
-99.65%

Contact Information

https://www.quantumbiopharma.com
NaN
55 University Ave., Toronto, ON, M5J 2H7

Company Facts

IPO DateJun 8, 2018
CountryCA
Actively Trading

Frequently Asked Questions